Open Access 01.12.2021 | Letter
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial
Erschienen in: Trials | Ausgabe 1/2021